Segra is a Plant Tissue Culture leader driving ag-tech innovation in the cannabis industry.
Under the guidance of Dr. Sma Zobayed, Segra’s Plant Tissue Culture Division is pioneering the future of cannabis tissue culture and young plant production. Segra’s flagship facility consists of state-of-the-art tissue culture production and research facilities, focused on the development of IP related to cannabis tissue culture protocols, micropropagation automation, and full-scale production testing from plantlet through flower.
This business division is led by Segra’s Chief Science Officer Dr. John Brunstein. Over the past 5 years, Segra has developed industry-leading quality assurance diagnostics for both cultivar DNA fingerprinting and pathogen detection. Research initiatives are focused on the development of IP related to genomics tools, bioinformatics systems, and marker assisted selection breeding programs.